A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

Clinical trial NCT07105059 · RECRUITING

Trial details

NCT number: NCT07105059
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2025-08-08
Primary completion: 2028-08-08
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.